Page last updated: 2024-12-08

3-deoxy-d-arabino-heptulosonate-7-phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-deoxy-D-arabino-heptulosonate-7-phosphate: do not confuse with 5-DAHP (5-dehydro-3-deoxyarabinoheptulosonic acid-7-phosphate) or with 2,4-DAHP (2,4-diaminohypoxanthine) which are also referred to as DAHP [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

7-phospho-2-dehydro-3-deoxy-D-arabino-heptonic acid : A ketoaldonic acid phosphate consisting of 2-dehydro-3-deoxy-D-arabino-heptonic acid having a phospho group at the 7-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID160647
CHEBI ID18150
SCHEMBL ID321570
MeSH IDM0061262

Synonyms (24)

Synonym
7-phospho-2-dehydro-3-deoxy-d-arabino-heptonic acid
3-deoxy-7-o-phosphono-d-arabino-hept-2-ulosonic acid
3-deoxy-d-arabino-2-heptulosonic acid 7-(dihydrogen phosphate)
CHEBI:18150
3-deoxy-d-arabino-heptulosonate-7-phosphate
3-deoxy-d-arabino-hept-2-ulosonate 7-phosphate
2-dehydro-3-deoxy-d-arabino-heptonate 7-phosphate
3-deoxy-d-arabino-heptulosonic acid 7-phosphate
3-deoxy-d-arabino-heptulosonate 7-phosphate
3-deoxy-arabino-heptulonate 7-phosphate
C04691
2627-73-8
2-dahp
(4r,5s,6r)-4,5,6-trihydroxy-2-oxo-7-phosphonooxyheptanoic acid
3-deoxy-d-arabino-2-heptulosonic acid
2-dehydro-3-deoxy-d-arabino-heptulosonic acid-7-phosphate
7-phospho-2-keto-3-deoxy-d-arabinoheptonate
d-arabino-2-heptulosonic acid, 3-deoxy-, 7-(dihydrogen phosphate)
3-deoxyarabinoheptulosonate-7-phosphate
SCHEMBL321570
PJWIPEXIFFQAQZ-PUFIMZNGSA-N
Q2690247
DTXSID30949135
3-deoxy-7-o-phosphonatohept-2-ulosonate

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Indigo production was thereafter improved by increasing the gene dosage of aroGfbr or by increasing substrate availability to DAHP synthase in vivo by either amplifying the tktA (transketolase) gene or inactivating both isozymes of pyruvate kinase."( Application of metabolic engineering to improve both the production and use of biotech indigo.
Berry, A; Dodge, TC; Pepsin, M; Weyler, W, 2002
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
ketoaldonic acid phosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Phenylalanine, tyrosine, and tryptophan biosynthesis012
shikimate pathway315

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (44.44)18.7374
1990's4 (14.81)18.2507
2000's10 (37.04)29.6817
2010's0 (0.00)24.3611
2020's1 (3.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.47 (24.57)
Research Supply Index3.37 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.57%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other27 (96.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]